Evaluation of site-selective drug effects on GABA receptors using nanovesicle-carbon nanotube hybrid devices - Archive ouverte HAL Access content directly
Journal Articles Biosensors and Bioelectronics Year : 2022

Evaluation of site-selective drug effects on GABA receptors using nanovesicle-carbon nanotube hybrid devices

Abstract

Site-selective drug effects on the ion-channel activities of γ-aminobutyric acid type A (GABAA) receptors are evaluated by using a nanovesicle-carbon nanotube hybrid device. Here, nanovesicles containing GABAA receptors are immobilized on the channel region of a carbon nanotube fieldeffect transistor. The receptor responses of this hybrid device to GABA are detected with a high sensitivity down to ~1 aM even in the presence of other neurotransmitters. Further, sensitivity differences between two GABAA-receptor-subunit compositions of α5β2γ2 and α1β2γ2 are assessed by normalizing the dose-dependent responses obtained from these hybrid devices. Specifically, the GABA concentration that produces 50% of maximal response (EC50) is obtained as ~10 pM for α5β2γ2 subunits and ~1 nM for α1β2γ2 subunits of GABAA receptor. Significantly, the potency profiles of both antagonist and agonist of GABAA receptor can be evaluated by analyzing EC50 values in the presence and absence of those drugs. A competitive antagonist increases the EC50 value of GABA by binding to the same site as GABA, while an allosteric agonist reduces it by binding to a different site. These results indicate that this hybrid device can be a powerful tool for the evaluation of candidate drug substances modulating GABA-mediated neurotransmission.
Fichier principal
Vignette du fichier
Park et al. Biosensors and Bioelectronics 2022_manuscript_ESI.pdf (2.27 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03668844 , version 1 (16-05-2022)

Identifiers

Cite

Inkyoung Park, Inwoo Yang, Youngtak Cho, Yoonji Choi, Junghyun Shin, et al.. Evaluation of site-selective drug effects on GABA receptors using nanovesicle-carbon nanotube hybrid devices. Biosensors and Bioelectronics, 2022, 200, pp.113903. ⟨10.1016/j.bios.2021.113903⟩. ⟨hal-03668844⟩
21 View
74 Download

Altmetric

Share

Gmail Facebook X LinkedIn More